Delayed
Bombay S.E.
09:57:17 16/05/2024 am IST
|
5-day change
|
1st Jan Change
|
1.35
INR
|
+2.27%
|
|
-0.75%
|
-22.81%
|
Fiscal Period: March |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
1,351
|
2,421
|
3,582
|
860.7
|
1,214
|
682.8
|
Enterprise Value (EV)
1 |
2,939
|
4,234
|
5,132
|
2,207
|
2,269
|
3,749
|
P/E ratio
|
-1.61
x
|
7.89
x
|
7.36
x
|
4.03
x
|
-1.06
x
|
-0.42
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.7
x
|
0.35
x
|
0.45
x
|
0.11
x
|
0.55
x
|
2.96
x
|
EV / Revenue
|
1.52
x
|
0.61
x
|
0.64
x
|
0.29
x
|
1.02
x
|
16.2
x
|
EV / EBITDA
|
-20.9
x
|
3.99
x
|
7.15
x
|
3.82
x
|
-5.28
x
|
-24.8
x
|
EV / FCF
|
8.14
x
|
-4.68
x
|
-82.8
x
|
13
x
|
3.54
x
|
-4.5
x
|
FCF Yield
|
12.3%
|
-21.4%
|
-1.21%
|
7.67%
|
28.2%
|
-22.2%
|
Price to Book
|
0.14
x
|
0.22
x
|
0.32
x
|
0.08
x
|
0.12
x
|
0.08
x
|
Nbr of stocks (in thousands)
|
1,37,440
|
1,94,440
|
2,04,440
|
2,04,440
|
2,04,440
|
2,04,440
|
Reference price
2 |
9.830
|
12.45
|
17.52
|
4.210
|
5.940
|
3.340
|
Announcement Date
|
04/09/17
|
17/09/18
|
04/09/19
|
02/09/20
|
08/09/21
|
27/06/23
|
Fiscal Period: March |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
1,936
|
6,963
|
8,000
|
7,576
|
2,216
|
231
|
EBITDA
1 |
-140.7
|
1,062
|
718.1
|
577
|
-430.1
|
-151
|
EBIT
1 |
-487.6
|
715.1
|
372.8
|
233.7
|
-773.7
|
-492.6
|
Operating Margin
|
-25.19%
|
10.27%
|
4.66%
|
3.08%
|
-34.91%
|
-213.3%
|
Earnings before Tax (EBT)
1 |
-949
|
257.4
|
463.7
|
192
|
-1,084
|
-1,890
|
Net income
1 |
-840
|
289.6
|
469.2
|
213.5
|
-1,145
|
-1,635
|
Net margin
|
-43.39%
|
4.16%
|
5.87%
|
2.82%
|
-51.68%
|
-708.07%
|
EPS
2 |
-6.112
|
1.578
|
2.379
|
1.044
|
-5.602
|
-7.999
|
Free Cash Flow
1 |
360.9
|
-904.3
|
-61.95
|
169.3
|
640.9
|
-833.5
|
FCF margin
|
18.64%
|
-12.99%
|
-0.77%
|
2.23%
|
28.92%
|
-360.9%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
29.34%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
79.31%
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
04/09/17
|
17/09/18
|
04/09/19
|
02/09/20
|
08/09/21
|
27/06/23
|
Fiscal Period: March |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
1,588
|
1,813
|
1,551
|
1,346
|
1,055
|
3,066
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-11.29
x
|
1.707
x
|
2.159
x
|
2.333
x
|
-2.453
x
|
-20.31
x
|
Free Cash Flow
1 |
361
|
-904
|
-62
|
169
|
641
|
-834
|
ROE (net income / shareholders' equity)
|
-8.22%
|
2.82%
|
4.28%
|
1.88%
|
-10.5%
|
-17.1%
|
ROA (Net income/ Total Assets)
|
-2.01%
|
2.84%
|
1.4%
|
0.87%
|
-2.95%
|
-2%
|
Assets
1 |
41,821
|
10,196
|
33,470
|
24,578
|
38,764
|
81,868
|
Book Value Per Share
2 |
71.20
|
55.30
|
55.00
|
56.00
|
50.70
|
42.70
|
Cash Flow per Share
2 |
0.0300
|
0.0200
|
0.0300
|
0.0500
|
0.0400
|
0
|
Capex
1 |
3.83
|
-
|
5.63
|
4.71
|
3.08
|
-
|
Capex / Sales
|
0.2%
|
-
|
0.07%
|
0.06%
|
0.14%
|
-
|
Announcement Date
|
04/09/17
|
17/09/18
|
04/09/19
|
02/09/20
|
08/09/21
|
27/06/23
|
|
1st Jan change
|
Capi.
|
---|
| -22.81% | 3.23M | | +17.44% | 66.52B | | +3.54% | 50.34B | | +18.03% | 42.01B | | +21.20% | 26.68B | | +13.22% | 19.97B | | +2.07% | 17.32B | | -11.70% | 14.99B | | -23.54% | 15.7B | | +2.57% | 15.53B |
Other Specialty Chemicals
|